Publication:
Clinical implications of blood pressure variability (BPV) in pregnancies: a review

Simple item page
dc.contributor.authorKasim, HHen_US
dc.contributor.authorMasri, MAen_US
dc.contributor.authorNoh, NAen_US
dc.contributor.authorMokhtar, Aen_US
dc.contributor.authorMokhtar, RHen_US
dc.date.accessioned2024-05-29T03:25:15Z
dc.date.available2024-05-29T03:25:15Z
dc.date.issued2019
dc.descriptionVolume : 39 Issues : 3en_US
dc.description.abstractBackground: Hypertension disorder in pregnancy (HDP) is the second most common contributor to maternal morbidity and mortality worldwide. Blood pressure variability (BPV), with the assistance of ambulatory blood pressure monitoring (ABPM), measures blood pressure readings in pregnant women and has the potential to predict the occurrence of pregnancy-induced hypertension (PIH) or preeclampsia (PE) before any symptoms develop. Methodology: Studies involving ABPM among pregnant women were identified using electronic databases such as PubMed, Scopus, Google Scholar, ScienceDirect, Medscape, Ovid and ProQuest. These electronic databases were assessed from 1990 to 2018. Keywords used to search for literatures included a combination of BPV matched with pregnancy, pregnant women and HDP, gestational hypertension and/or PE. Results: Out of 21,526 articles identified, a total of 10 studies met the criteria. Seven articles used the spectral analysis method while another two articles used a combination of spectral analysis, time domain and a nonlinear method for BPV analysis. The final article described BPV as vagal baroreflex. Four articles agreed that high frequency (HF) BPV was mainly dominant from the second trimester until 4 days postpartum in HDP patients. This reflects the dominant features of parasympathetic activities among these patients. Two articles that used time domain also agreed that standard deviation (SD) BPV increased in PE patients. Conclusions: In pregnancy, BPV has a strong impact on the knowledge understanding of the disease in clinical fields, allows a superior ability to predict PIH and PE in mid-pregnancy and offers potential value for addressing hypertension in pregnancy.en_US
dc.identifier.doi10.1515/hmbci-2018-0060
dc.identifier.doihttps://www.degruyter.com/document/doi/10.1515/hmbci-2018-0060/html
dc.identifier.isbn1868-1891
dc.identifier.issn1868-1883
dc.identifier.issue3
dc.identifier.scopusWOS:000488243200004
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85061131183&doi=10.1515%2fhmbci-2018-0060&partnerID=40&md5=2a53d78db5b96a5e7a08d6582ef63d67
dc.identifier.urihttps://oarep.usim.edu.my/handle/123456789/11922
dc.identifier.volume39
dc.languageEnglish
dc.language.isoen_USen_US
dc.publisherWalter De Gruyter GMBHen_US
dc.relation.ispartofHormone Molecular Biology And Clinical Investigationen_US
dc.sourceWeb Of Science (ISI)
dc.subjectABPMen_US
dc.subjectblood pressure variabilityen_US
dc.subjectBPVen_US
dc.subjecthypertension disorder in pregnancyen_US
dc.subjectPEen_US
dc.subjectPIHen_US
dc.titleClinical implications of blood pressure variability (BPV) in pregnancies: a reviewen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Collections

Web of Science_WoS